{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"5","upperLimit":"10","value":"7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"40"}],"units":"Participants"}],"description":"Overall survival was defined as the time from the date of registration to the date of death due to any cause. Patients last known to be alive are censored at date of last contact.","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients receive E7389 IV on days 1 and 8 of an every 21-day cycle.","id":"OG000","title":"Treatment (E7389 IV)"}],"paramType":"MEDIAN","populationDescription":"Only eligible patients were included in the analysis.","reportingStatus":"POSTED","timeFrame":"Every 3 months for first year, then every six months thereafter up to a maximum of 3 years from registration.","title":"Overall Survival","type":"SECONDARY","unitOfMeasure":"months"}